This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Wound Catheter Vs LA Bolus in Renal Transplant: RCT

Sponsored by The Leeds Teaching Hospitals NHS Trust

About this trial

Last updated 2 years ago

Study ID

GS21/138922

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 100 Years
All
All

Trial Timing

Ended 2 years ago

What is this trial about?

Pain control is an important part of patients' care after a kidney transplant. Currently patients receive a one off injection of Local Anaesthetic (LA) in the wound at the end of the operation followed by Intravenous morphine through a Patient Controlled Analgesia System (PCAS), a button pressed to provide a calculated dose with lock out times for safety. Through this study the aim to test the efficiency of Continuous Local Anaesthetic Infiltration via Wound Catheter (LAWC) which is a method to deliver Local Anaesthetic over a longer period of time after the operation. LAWC are currently in use in a variety of surgical specialities including Liver surgery. Patients participating in this study will be allocated randomly to one of 2 groups; one will receive LA at the end of the operation as per current practice and one will receive LAWC. It then compare outcomes such as the the dose of morphine required in the PCAS, quality of pain control and improvement in recovery.

What are the participation requirements?

Yes

Inclusion Criteria

- Primary kidney transplantation

- Single kidney transplantation

- Signed informed Consent

No

Exclusion Criteria

- Midline laparotomy

- Dual kidney transplantation

- Kidney re-transplantation

- Multi-organ transplantation

- Patients on Long term opiates

- Patients with psychiatric illness

Locations

Location

Status

Recruiting
Completed